Announced details
The Company's employees will present at the academic conference. Researchers from Tokyo University of Agriculture and Technology, Tokyo Metropolitan University, and Yamagata University are also participating as authors of the first presentation.
An academic society established to promote basic and applied research related to antibodies, make academic contributions to industries including the diagnostics and healthcare sectors, foster public understanding and adoption of antibodies, develop human resources, and facilitate exchanges among researchers in Japan and overseas.
Fukuoka International Congress Center (conference venue)
The acceptance demonstrates the Company's research and development capabilities and technological superiority, and is expected to make a significant contribution to future business growth.
The company does not address Contract Value / Offering price.
| Item | Details |
|---|---|
| Names of Products / Services Covered | Gattai Technology, Efficient selection of rabbit antibody-producing cells using an anti-CD138 antibody |
| Counterparty | Japanese Society for Antibodies |
| Counterparty overview | An academic society established to promote basic and applied research related to antibodies, make academic contributions to industries including the diagnostics and healthcare sectors, foster public understanding and adoption of antibodies, develop human resources, and facilitate exchanges among researchers in Japan and overseas. |
| Relationship with the Company | The Company's employees will present at the academic conference. Researchers from Tokyo University of Agriculture and Technology, Tokyo Metropolitan University, and Yamagata University are also participating as authors of the first presentation. |
| Launch date | 9–11 December 2026 (presentations scheduled) |
| Applicable area | Antibody Research, Diagnostics and healthcare |
| Location | Fukuoka International Congress Center (conference venue) |
| Impact on Business Performance | The acceptance demonstrates the Company's research and development capabilities and technological superiority, and is expected to make a significant contribution to future business growth. |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company states that the acceptance demonstrates its research and development capabilities and technological superiority, and is expected to make a significant contribution to future business growth.